Stem Cell Therapy For Multiple Sclerosis Global Market Report 2025
상품코드:1889592
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
다발성 경화증용 줄기세포 치료 시장 규모는 최근 급속도로 확대되고 있습니다. 2024년의 16억 2,000만 달러에서 2025년에는 18억 2,000만 달러로, CAGR 12.6%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장은 재생 의료에 대한 수요 증가, 다발성 경화증의 이환율 상승, 줄기세포 치료에 대한 인지도 향상, 줄기세포 조사에 대한 투자 확대, 줄기세포 치료의 효능을 나타내는 임상 성과 개선 등의 요인과 관련이 있습니다.
다발성 경화증용 줄기세포 치료 시장 규모는 향후 수년간 빠른 성장이 예상됩니다. 2029년에는 28억 9,000만 달러에 달하고, CAGR은 12.3%를 나타낼 전망입니다. 예측기간의 성장은 맞춤형 의료에 대한 수요 증가, 저침습치료를 선호하는 환자 증가, 재생의료센터의 확대, 선진치료에 대한 보험 적용 범위의 확대, 생명공학기업과 연구기관 간의 연계 강화에 의해 견인될 전망입니다. 예측기간의 주요 동향에는 줄기세포 전달방법의 기술적 진보, 유전자 편집 및 재생기술의 발전, 면역조절요법의 혁신, 신규 치료법에 대한 연구개발 투자 증가, 세포치료를 지원하는 생체재료의 진보 등이 있습니다.
다발성 경화증(MS)의 유병률 증가는 미래의 다발성 경화증용 줄기세포 치료 시장의 확대에 크게 기여할 것으로 예상됩니다. 다발성 경화증은 신경 섬유를 덮는 보호막인 미엘린을 손상시켜 중추신경계에 영향을 미치는 만성 자가면역질환으로 뇌와 신체 간의 정보전달을 방해하고 피로, 근력저하, 시각장애 등의 증상을 일으킵니다. MS의 증례 수 증가는 주로 진단기술의 진보에 의한 것으로, 의료영상기술의 향상과 인지도의 상승에 의해 보다 정확하고 조기에 검출이 가능하게 되어, 보고 증례 수가 증가하고 있습니다. 다발성 경화증용 줄기세포 치료는 손상된 미엘린 복구, 비정상적인 면역반응 조절, 신경세포 재생 촉진에 도움이 되며, 증상을 완화하고 질병 진행을 늦출 수 있습니다. 예를 들면, 2024년 5월에 영국을 거점으로 하는 단체 'MS 트러스트'가 발표한 보고서에 의하면, 세계에서 약 290만명이 다발성 경화증의 영향을 받고 있었으며, 영국만으로도 15만명 이상이 이 질환과 함께 생활하고 있었습니다. 그러므로 다발성 경화증의 유병률 증가는 다발성 경화증용 줄기세포 치료 시장의 성장을 가속할 것으로 예측됩니다.
다발성 경화증용 줄기세포 치료 시장의 주요 기업은 재발완화형 및 진행형 다발성 경화증 환자에 대한 치료의 효능, 안전성, 재생가능성을 향상시키기 위해 지방 유래 간엽계 줄기세포(ADMSC) 등의 혁신적인 치료법의 개발에 주력하고 있습니다. 지방 유래 간엽계 줄기세포(ADMSCs)는 지방조직으로부터 채취되는 만능 줄기세포이며, 다양한 세포 유형으로 분화 가능하며 재생능력과 면역조절 특성을 가지고 있습니다. 이러한 특성은 다발성 경화증과 같은 자가면역 질환 및 신경퇴행성 질환의 치료에 유용합니다. 예를 들어, 2025년 8월에는 미국에 본사를 둔 바이오 의약품 기업인 호프 바이오사이언스사가 고용량 주입과 32주에 걸친 반복 투여에 의해 지방 유래 간엽계 줄기세포를 투여하는 'HB-adMSCs' 요법을 발표했습니다. 이 치료법은 면역조절작용과 신경재생작용의 메커니즘을 겸비하고 있으며, 질환의 진행을 늦추고, 미엘린 손상을 수복할 가능성을 갖고 있어, 종래의 면역억제요법과 차별화된 치료법입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 다발성 경화증용 줄기세포 치료 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 다발성 경화증용 줄기세포 치료 시장 : 성장률 분석
세계의 다발성 경화증용 줄기세포 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 다발성 경화증용 줄기세포 치료 시장 예측 : 규모와 성장(2024-2029년, 2034F)
세계의 다발성 경화증용 줄기세포 치료 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 다발성 경화증용 줄기세포 치료 시장 : 줄기세포 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
배아 줄기세포
성체 줄기세포
유도 만능 줄기세포
중간엽 줄기세포
조혈 줄기세포
세계의 다발성 경화증용 줄기세포 치료 시장 : 치료 접근법별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
자가 줄기세포 치료
동종 줄기세포 치료
세계의 다발성 경화증용 줄기세포 치료 시장 : 투여 방법별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
정맥내 주사
수강내 주사
척수내 직접 투여
세계의 다발성 경화증용 줄기세포 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
재발완화형 다발성 경화증(RRMS)
원발성 진행형 다발성 경화증(PPMS)
2차 진행형 다발성 경화증(SPMS)
진행재발형 다발성 경화증(PRMS)
세계의 다발성 경화증용 줄기세포 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
병원
전문 클리닉
연구기관
기타 최종 사용자
세계의 다발성 경화증용 줄기세포 치료 시장 세분화 : 배아 줄기세포, 유형별, 분석과 예측
내세포괴세포
배반포 유래 세포
만능 줄기세포
세계의 다발성 경화증용 줄기세포 치료 시장 세분화 : 성체 줄기세포, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
골수 줄기세포
신경 줄기세포
조직 특이적 줄기세포
세계의 다발성 경화증용 줄기세포 치료 시장 세분화 : 유도 만능 줄기세포, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
체세포 재프로그래밍
환자 유래 세포
세계의 다발성 경화증용 줄기세포 치료 시장 세분화 : 간엽계 줄기세포, 유형별, 분석과 예측
지방 유래 줄기세포
제대 유래 줄기세포
골수 유래 줄기세포
세계의 다발성 경화증용 줄기세포 치료 시장 세분화 : 조혈 줄기세포, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
말초혈 줄기세포
골수 줄기세포
제대혈 줄기세포
제7장 지역별 및 국가별 분석
세계의 다발성 경화증용 줄기세포 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
세계의 다발성 경화증용 줄기세포 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
다발성 경화증용 줄기세포 치료 시장 : 경쟁 구도
다발성 경화증용 줄기세포 치료 시장 : 기업 프로파일
Sana Biotechnology Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Century Therapeutics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Reelabs Private Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
PlacidWay LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
MedAccess Guarantee Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Celltex Therapeutics Corporation
CELLTEX THERAPEUTICS CORP
BrainStorm Cell Therapeutics Ltd.
Athersys Inc.
Advancells Dermaceuticals Private Limited
ImStem Biotechnology Inc.
NeuroGenesis Bio Inc.
Stem Cell Medicine Ltd.
Biotherapy International
R3 Stem Cell
Hope Biosciences LLC
FibroBiologics Inc.
Global Institute of Stem Cell Therapy and Research Inc.
ProgenCell
Stemwell
제32장 세계 시장의 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
다발성 경화증용 줄기세포 치료 시장(2029년) : 새로운 기회를 제공하는 국가
다발성 경화증용 줄기세포 치료 시장(2029년) : 새로운 기회를 제공하는 부문
다발성 경화증용 줄기세포 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Stem cell therapy for multiple sclerosis is a regenerative medical treatment that uses stem cells to repair nerve damage and restore immune system balance in individuals with multiple sclerosis, an autoimmune disease that attacks the myelin sheath protecting nerve fibers. The therapy aims to halt disease progression, reduce inflammation, and support the regeneration of damaged nervous tissue.
The main components of stem cell therapy for multiple sclerosis include embryonic stem cells, adult stem cells, induced pluripotent stem cells, mesenchymal stem cells, and hematopoietic stem cells. Stem cell therapy for multiple sclerosis using embryonic stem cells involves transplanting pluripotent cells derived from early-stage embryos to repair damaged myelin and promote neural regeneration. Treatment approaches include autologous stem cell therapy and allogeneic stem cell therapy. Delivery methods include intravenous injection, intrathecal injection, and direct intraspinal administration. Applications encompass relapsing-remitting multiple sclerosis (RRMS), primary progressive multiple sclerosis (PPMS), secondary progressive multiple sclerosis (SPMS), and progressive relapsing multiple sclerosis (PRMS). End users include hospitals, specialty clinics, research institutes, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The stem cell therapy for multiple sclerosis market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy for multiple sclerosis market statistics, including stem cell therapy for multiple sclerosis industry global market size, regional shares, competitors with a stem cell therapy for multiple sclerosis market share, detailed stem cell therapy for multiple sclerosis market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy for multiple sclerosis industry. This stem cell therapy for multiple sclerosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stem cell therapy for multiple sclerosis market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be linked to increasing demand for regenerative medicine, a rising prevalence of multiple sclerosis, growing awareness of stem cell therapies, increasing investment in stem cell research, and improving clinical outcomes demonstrating the effectiveness of stem cell therapy.
The stem cell therapy for multiple sclerosis market size is expected to see rapid growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be driven by rising demand for personalized medicine, growing patient preference for minimally invasive treatments, the expansion of regenerative therapy centers, increasing insurance coverage for advanced treatments, and strengthening collaborations between biotech companies and research institutions. Major trends in the forecast period include technological advancements in stem cell delivery methods, progress in gene editing and regenerative techniques, innovations in immunomodulatory therapies, increased research and development investment for novel treatments, and advancements in biomaterials supporting cell therapy.
The growing prevalence of multiple sclerosis (MS) is expected to significantly contribute to the expansion of the stem cell therapy market for multiple sclerosis in the future. Multiple sclerosis is a chronic autoimmune condition that affects the central nervous system by damaging the protective myelin sheath around nerve fibers, leading to disrupted communication between the brain and the body, and causing symptoms such as fatigue, muscle weakness, and vision problems. The rising number of MS cases is mainly due to advancements in diagnostic techniques, as improvements in medical imaging and increased awareness allow for more accurate and earlier detection, resulting in a higher number of reported cases. Stem cell therapy for multiple sclerosis helps repair damaged myelin, modulate abnormal immune responses, and encourage nerve cell regeneration, potentially reducing symptoms and slowing disease progression. For example, in May 2024, the MS Trust, a UK-based organization, published a report stating that approximately 2.9 million people worldwide are affected by multiple sclerosis, with over 150,000 individuals in the UK living with the condition. Therefore, the increasing prevalence of multiple sclerosis is expected to drive the growth of the stem cell therapy market for multiple sclerosis.
Leading companies in the stem cell therapy for multiple sclerosis market are focusing on developing innovative treatments, such as adipose-derived mesenchymal stem cells, to improve the efficacy, safety, and regenerative potential of therapies for patients with relapsing-remitting and progressive forms of multiple sclerosis. Adipose-derived mesenchymal stem cells (ADMSCs) are multipotent stem cells obtained from adipose (fat) tissue that can differentiate into various cell types and possess regenerative and immunomodulatory properties that are beneficial in treating autoimmune and neurodegenerative diseases like multiple sclerosis. For instance, in August 2025, Hope Biosciences, LLC, a U.S.-based biopharmaceutical company, introduced its HB-adMSCs therapy, which uses adipose-derived mesenchymal stem cells administered via high-dose infusions and repeat dosing over a 32-week period. The therapy combines immunomodulatory and neuroregenerative mechanisms, offering the potential to slow disease progression and repair myelin damage, setting it apart from conventional immunosuppressive treatments.
In November 2024, Pluri Inc., an Israel-based biotechnology company, partnered with Brainstorm Cell Therapeutics Ltd. Through this collaboration, Pluri Inc. aims to advance the development and commercialization of innovative regenerative therapies in partnership with Brainstorm Cell Therapeutics, combining their expertise to accelerate clinical research and improve treatment outcomes for patients. Brainstorm Cell Therapeutics Ltd. is a U.S.-based biotechnology company that specializes in stem cell therapy for multiple sclerosis.
Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell
North America was the largest region in the stem cell therapy for multiple sclerosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell therapy for multiple sclerosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the stem cell therapy for multiple sclerosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The stem cell therapy for multiple sclerosis market includes revenues earned by providing services such as stem cell collection and processing services, cryopreservation and storage services, patient preconditioning services, post-therapy rehabilitation services, and immune system profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stem Cell Therapy For Multiple Sclerosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on stem cell therapy for multiple sclerosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for stem cell therapy for multiple sclerosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stem cell therapy for multiple sclerosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type Of Stem Cell: Embryonic Stem Cells; Adult Stem Cells; Induced Pluripotent Stem Cells; Mesenchymal Stem Cells; Hematopoietic Stem Cells
4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells; Umbilical Cord Derived Stem Cells; Bone Marrow Derived Stem Cells
5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells; Bone Marrow Stem Cells; Umbilical Cord Blood Stem Cells
Companies Mentioned: Sana Biotechnology Inc.; Century Therapeutics Inc.; Reelabs Private Limited; PlacidWay LLC; MedAccess Guarantee Ltd; Celltex Therapeutics Corporation; CELLTEX THERAPEUTICS CORP; BrainStorm Cell Therapeutics Ltd.; Athersys Inc.; Advancells Dermaceuticals Private Limited; ImStem Biotechnology Inc.; NeuroGenesis Bio Inc.; Stem Cell Medicine Ltd.; Biotherapy International; R3 Stem Cell; Hope Biosciences LLC; FibroBiologics Inc.; Global Institute of Stem Cell Therapy and Research Inc.; ProgenCell; Stemwell
Countries:
Table of Contents
1. Executive Summary
2. Stem Cell Therapy For Multiple Sclerosis Market Characteristics
3. Stem Cell Therapy For Multiple Sclerosis Market Trends And Strategies
4. Stem Cell Therapy For Multiple Sclerosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Stem Cell Therapy For Multiple Sclerosis Growth Analysis And Strategic Analysis Framework
5.1. Global Stem Cell Therapy For Multiple Sclerosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Stem Cell Therapy For Multiple Sclerosis Market Growth Rate Analysis
5.4. Global Stem Cell Therapy For Multiple Sclerosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Stem Cell Therapy For Multiple Sclerosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Stem Cell Therapy For Multiple Sclerosis Total Addressable Market (TAM)
6. Stem Cell Therapy For Multiple Sclerosis Market Segmentation
6.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Embryonic Stem Cells
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells
Hematopoietic Stem Cells
6.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Stem Cell Therapy
Allogeneic Stem Cell Therapy
6.3. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Injection
Intrathecal Injection
Direct Intraspinal Administration
6.4. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)
6.5. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Institutes
Other End-Users
6.6. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inner Cell Mass Cells
Blastocyst Derived Cells
Totipotent Stem Cells
6.7. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Marrow Stem Cells
Neural Stem Cells
Tissue Specific Stem Cells
6.8. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Induced Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reprogrammed Somatic Cells
Patient Derived Cells
6.9. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adipose Derived Stem Cells
Umbilical Cord Derived Stem Cells
Bone Marrow Derived Stem Cells
6.10. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral Blood Stem Cells
Bone Marrow Stem Cells
Umbilical Cord Blood Stem Cells
7. Stem Cell Therapy For Multiple Sclerosis Market Regional And Country Analysis
7.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market
8.1. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Stem Cell Therapy For Multiple Sclerosis Market
9.1. China Stem Cell Therapy For Multiple Sclerosis Market Overview
9.2. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Stem Cell Therapy For Multiple Sclerosis Market
10.1. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Stem Cell Therapy For Multiple Sclerosis Market
11.1. Japan Stem Cell Therapy For Multiple Sclerosis Market Overview
11.2. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Stem Cell Therapy For Multiple Sclerosis Market
12.1. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Stem Cell Therapy For Multiple Sclerosis Market
13.1. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Stem Cell Therapy For Multiple Sclerosis Market
14.1. South Korea Stem Cell Therapy For Multiple Sclerosis Market Overview
14.2. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Stem Cell Therapy For Multiple Sclerosis Market
15.1. Western Europe Stem Cell Therapy For Multiple Sclerosis Market Overview
15.2. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Stem Cell Therapy For Multiple Sclerosis Market
16.1. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Stem Cell Therapy For Multiple Sclerosis Market
17.1. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Stem Cell Therapy For Multiple Sclerosis Market
18.1. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Stem Cell Therapy For Multiple Sclerosis Market
19.1. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Stem Cell Therapy For Multiple Sclerosis Market
20.1. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market
21.1. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market Overview
21.2. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Stem Cell Therapy For Multiple Sclerosis Market
22.1. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Stem Cell Therapy For Multiple Sclerosis Market
23.1. North America Stem Cell Therapy For Multiple Sclerosis Market Overview
23.2. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Stem Cell Therapy For Multiple Sclerosis Market
24.1. USA Stem Cell Therapy For Multiple Sclerosis Market Overview
24.2. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Stem Cell Therapy For Multiple Sclerosis Market
25.1. Canada Stem Cell Therapy For Multiple Sclerosis Market Overview
25.2. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Stem Cell Therapy For Multiple Sclerosis Market
26.1. South America Stem Cell Therapy For Multiple Sclerosis Market Overview
26.2. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Stem Cell Therapy For Multiple Sclerosis Market
27.1. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Stem Cell Therapy For Multiple Sclerosis Market
28.1. Middle East Stem Cell Therapy For Multiple Sclerosis Market Overview
28.2. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Stem Cell Therapy For Multiple Sclerosis Market
29.1. Africa Stem Cell Therapy For Multiple Sclerosis Market Overview
29.2. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape And Company Profiles
30.1. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape
30.2. Stem Cell Therapy For Multiple Sclerosis Market Company Profiles
30.2.1. Sana Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Century Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Reelabs Private Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. PlacidWay LLC Overview, Products and Services, Strategy and Financial Analysis
30.2.5. MedAccess Guarantee Ltd Overview, Products and Services, Strategy and Financial Analysis
31. Stem Cell Therapy For Multiple Sclerosis Market Other Major And Innovative Companies
31.1. Celltex Therapeutics Corporation
31.2. CELLTEX THERAPEUTICS CORP
31.3. BrainStorm Cell Therapeutics Ltd.
31.4. Athersys Inc.
31.5. Advancells Dermaceuticals Private Limited
31.6. ImStem Biotechnology Inc.
31.7. NeuroGenesis Bio Inc.
31.8. Stem Cell Medicine Ltd.
31.9. Biotherapy International
31.10. R3 Stem Cell
31.11. Hope Biosciences LLC
31.12. FibroBiologics Inc.
31.13. Global Institute of Stem Cell Therapy and Research Inc.
31.14. ProgenCell
31.15. Stemwell
32. Global Stem Cell Therapy For Multiple Sclerosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Stem Cell Therapy For Multiple Sclerosis Market
34. Recent Developments In The Stem Cell Therapy For Multiple Sclerosis Market
35. Stem Cell Therapy For Multiple Sclerosis Market High Potential Countries, Segments and Strategies
35.1 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
